Related Experiment Video
Updated: Sep 25, 2025

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
Historical and pathological overview of Castleman disease
Midori Filiz Nishimura1, Yoshito Nishimura2,3, Asami Nishikori4
1Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Insights
Castleman disease, a lymphoproliferative disorder, presents challenges due to varied subtypes and causes. This review clarifies its historical evolution, subtypes like multicentric Castleman disease (MCD), and histopathological features.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Castleman disease encompasses diverse lymphoproliferative subtypes with shared lymph node histology but varied clinical presentations and etiologies.
- Unicentric Castleman disease (UCD) is localized, while multicentric Castleman disease (MCD) presents with systemic symptoms and multiple lesions.
- MCD classification includes KSHV/HHV8-related, POEMS syndrome-associated, and idiopathic subtypes, each with distinct characteristics.
Purpose of the Study:
- To elucidate the historical development and evolving understanding of Castleman disease.
- To review current classifications and definitions within the multicentric Castleman disease (MCD) spectrum.
- To summarize key histopathological findings across Castleman disease subtypes.
Main Methods:
- Review of historical literature and seminal reports on Castleman disease.
- Analysis of current diagnostic criteria and classifications for MCD subtypes.
- Synthesis of histopathological features associated with UCD and various MCD forms.
Main Results:
- Castleman disease has evolved from UCD to include complex MCD subtypes.
- MCD is subcategorized based on KSHV/HHV8 status, association with POEMS syndrome, or idiopathic origins.
- Histopathological examination remains crucial for differentiating subtypes and understanding disease mechanisms.
Conclusions:
- A comprehensive understanding of Castleman disease requires appreciating its historical context and diverse subtypes.
- Accurate classification of MCD, considering viral status and associated syndromes, is essential for patient management.
- Further research into idiopathic MCD is needed due to its heterogeneous nature and overlapping features.
Abstract:
Castleman disease consists of several lymphoproliferative subtypes that share some histological features in the lymph nodes. On the other hand, numerous clinical findings and etiologies make the disease challenging to understand. The origin of the disease is the hyaline vascular-type unicentric Castleman disease (UCD), first reported by Benjamin Castleman et al. in 1954. Although UCD is characterized by localized lesions and lack of symptoms, multicentric Castleman disease (MCD) with multiple lesions and systemic symptoms was reported by Frizzera in 1983. MCD is further divided according to KSHV/HHV8 infection status. In KSHV/HHV8-related MCD, viral infection signals lead to excessive cytokine production, and cause clinical and pathologic abnormalities. Some cases of plasma cell-type KSHV/HHV8-negative MCD can be found in association with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, M-proteins, and skin changes), which is a paraneoplastic syndrome. The others are idiopathic MCD, which are currently considered a heterogeneous group of diseases with overlapping pathological and clinical features. In this article, we summarize the historical evolution of Castleman disease to help understand the disease concept. We also review the latest ideas and definitions of the subtypes within the MCD spectrum and summarize the histopathological findings.
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Coronary Artery Disease I: Introduction
Lysosomal Hydrolases

